Novel intermediate form of serotonin receptor identified as therapeutic target for psychiatric disorders

Misha Kudryshev’s lab at the Max Delbrück Center has identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia.

Leave a Reply